Home
/
TENAX THERAPEUTICS, INC.
/
Financials
/
Quarterly
TENAX THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that TENAX THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2015
Jan 31, 2015
$0
Mar 17, 2015
Q2
2015
Oct 31, 2014
$0
Dec 15, 2014
Q1
2015
Jul 31, 2014
$0
Sep 15, 2014
Q3
2014
Jan 31, 2014
$41.9K
Mar 17, 2014
Q2
2014
Oct 31, 2013
$55.7K
Dec 17, 2013
Q1
2014
Jul 31, 2013
$165.8K
Sep 17, 2013
Q3
2013
Jan 31, 2013
$222.4K
Mar 18, 2013
Q2
2013
Oct 31, 2012
$514.9K
Dec 14, 2012
Q1
2013
Jul 31, 2012
$272.1K
Sep 19, 2012
Q3
2012
Jan 31, 2012
$148.3K
Mar 15, 2012
Q2
2012
Oct 31, 2011
$95.2K
Dec 15, 2011
Q1
2013
Jul 31, 2011
$24.9K
Sep 19, 2012
Q3
2012
Jan 31, 2011
$26.6K
Mar 15, 2012
Q2
2012
Oct 31, 2010
$27.1K
Dec 15, 2011
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 12, 2025
Q2
2025
Jun 30, 2025
$0
Aug 13, 2025
Q1
2025
Mar 31, 2025
$0
May 14, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($15.80M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($10.85M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($10.85M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($10.41M)
Aug 13, 2025
Q3
2025
Mar 31, 2025
($10.41M)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($10.41M)
May 14, 2025
Q3
2025
Sep 30, 2024
($3.96M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($3.58M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($3.58M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($3.80M)
May 14, 2025
Q3
2025
Mar 31, 2024
($3.80M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($3.80M)
Aug 13, 2025
Q3
2024
Sep 30, 2023
$1.97M
Nov 13, 2024
Q3
2024
Jun 30, 2023
($1.11M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
$1.11M
Aug 13, 2024
Q3
2024
Mar 31, 2023
($1.41M)
Nov 13, 2024
Q2
2023
Mar 31, 2023
($1.41M)
Aug 14, 2023
Q1
2024
Mar 31, 2023
$1.41M
May 14, 2024
Q3
2023
Sep 30, 2022
$2.92M
Nov 13, 2023
Q3
2023
Jun 30, 2022
($2.86M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($16.81M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($11.79M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($11.34M)
May 14, 2025
Q3
2025
Sep 30, 2024
($4.62M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($3.67M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($3.91M)
May 14, 2025
Q3
2024
Sep 30, 2023
$2.12M
Nov 13, 2024
Q2
2024
Jun 30, 2023
$1.24M
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.54M)
May 14, 2024
Q3
2023
Sep 30, 2022
$2.92M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$2.86M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$2.72M
May 15, 2023
Q3
2022
Sep 30, 2021
$3.80M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$1.96M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$23.75M
May 16, 2022
Q3
2021
Sep 30, 2020
$2.23M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$2.14M
Aug 16, 2021
Q1
2021
Mar 31, 2020
$2.67M
May 17, 2021
Q3
2020
Sep 30, 2019
$2.26M
Nov 16, 2020
Q2
2020
Jun 30, 2019
$1.82M
Aug 14, 2020